83.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie
Soleno stock maintains Overweight rating at Piper Sandler on VYKAT XR outlook - Investing.com India
Trend Tracker for (SLNO) - news.stocktradersdaily.com
High Growth Tech Stocks in US for June 2025 - Yahoo Finance
Capnia Inc stock soars to 52-week high, hits $81.03 By Investing.com - Investing.com Nigeria
Capnia Inc stock soars to 52-week high, hits $81.03 - Investing.com
Soleno Therapeutics Insiders Sell US$39m Of Stock, Possibly Signalling Caution - simplywall.st
Transcript : Soleno Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener
Soleno Therapeutics Holds Annual Stockholders Meeting - TipRanks
Transcript : Soleno Therapeutics, Inc.Shareholder/Analyst Call - marketscreener.com
Trading (SLNO) With Integrated Risk Controls - news.stocktradersdaily.com
Soleno Therapeutics’ SWOT analysis: vykat xr launch propels stock amid rare disease market potential - Investing.com India
Stifel maintains Soleno Therapeutics stock Buy rating, $108 target - Investing.com
Stifel maintains Soleno Therapeutics stock Buy rating, $108 target By Investing.com - Investing.com India
EMA validates Soleno’s application for Prader-Willi syndrome treatment - Yahoo Finance
(SLNO) Trading Report - news.stocktradersdaily.com
Soleno Therapeutics seeking regulatory approval in treatment of PWS - Yahoo Finance
Sector Update: Health Care Stocks Flat to Lower Pre-Bell Friday - marketscreener.com
Cantor Fitzgerald maintains Overweight on Soleno Therapeutics stock By Investing.com - Investing.com South Africa
Soleno Application for Hyperphagia Treatment in Patients with Prader-Willi Syndrome Gets European Validation - marketscreener.com
Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR - Insider Monkey
Soleno seeks EU approval for Prader-Willi syndrome treatment - Investing.com Australia
Soleno seeks EU approval for Prader-Willi syndrome treatment By Investing.com - Investing.com Canada
Soleno Therapeutics' (SLNO) MAA for PWS Treatment Validated by EMA | SLNO Stock News - GuruFocus
Soleno Therapeutics Announces Submission and EMA Validation - GlobeNewswire
Soleno's PWS Drug VYKAT Advances in Europe After Recent FDA ApprovalKey Details for Investors - Stock Titan
BCE Inc: Stock Forecast & Analysis - The Globe and Mail
Buy AT&T or Verizon Stock if Market Volatility Resurges? - The Globe and Mail
Cantor Fitzgerald maintains Overweight on Soleno Therapeutics stock - Investing.com Australia
Soleno Therapeutics to Participate in Upcoming June Conferences - GlobeNewswire
Lowe’s Stock Uptrend Can Continue for These 2 Reasons - The Globe and Mail
Rare Disease Leader Soleno Therapeutics Secures Speaking Slots at Major Healthcare Conferences - Stock Titan
Piper Sandler maintains $145 target on Soleno Therapeutics stock - Investing.com Australia
Soleno reports positive VYKAT XR results for Prader-Willi syndrome By Investing.com - Investing.com South Africa
Piper Sandler maintains $145 target on Soleno Therapeutics stock By Investing.com - Investing.com Canada
Soleno reports positive VYKAT XR results for Prader-Willi syndrome - Investing.com Australia
Soleno Therapeutics (SLNO) Reports Promising Vykat XR Study Resu - GuruFocus
Soleno Therapeutics (SLNO) Reports Promising Vykat XR Study Results | SLNO Stock News - GuruFocus
Soleno Therapeutics Presents Positive Clinical Data for VYKAT™ XR at the 2025 Pediatric Endocrine Society Annual Meeting - Nasdaq
Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants wi - The Manila Times
VYKAT XR Clinical Data Shows Major Improvements in Prader-Willi Syndrome Symptoms | SLNO Stock News - Stock Titan
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Company News for May 19, 2025 - The Globe and Mail
Northern Trust Corp Buys 34,309 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at PES 2025 - GlobeNewswire
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):